本文透過整理與人類基因智財權相關之權利主體，並以「基本價值理論」歸納其權源性質及其對應之保護模式，所推出的規範方針之建議。在本文以權源性質之界定為中心的立論中，是根據對應性之結構引導出結論：性質為「自我決定」之權源，其權利主體即有權主張侵害之排除，惟此「自由」之權源，亦可轉化為處分權限，因而可以透過契約自由從事買賣或授權等行為，轉為分享經濟獲益之基礎；相對的，性質為「基礎生存所需」之權源，則需要國家積極作為來加以維護；性質為「安全」的權源，就會導向尊重現有秩序之穩定性的推論。這些論據部份為人體組織自由交易秩序提供了正當性基礎，同時也強調了意思自主之重要性；部份卻也提供了國家管制措施的介入空間。

Abstract The author attempted to construct some fundamental principles to decide the difficult question in human genomic technology： who owns the property rights in human biological materials. The considerations based on the thought："who" has "what" contribution to achieve the intelligence property right. Through analyzing the three groups of contributors and the qualities of their donation, the author suggests a way of multiple participations as a reasonable solution.